Strategic Direction - Leverage 2017 Milestones
Post# of 72433
- Leverage 2017 Milestones to Support Partnering Opportunities
• Multiple CDAs Signed, Ongoing Interactions with Big Pharma and other Global Rx Companies
- Advance Formulation Work to Tailor Drug Delivery
- Continue to Build Value by Addressing Areas of Unmet Medical Need for
the Benefit of Patients and Shareholders
- Anchor Each Drug Candidate in Additional Trials to Further Provide
Favorable Return-On-Investment
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)